RG
OXFD

Redmile Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Redmile Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,796,477
Closed -$24.7M – 88
2019
Q2 		$24.7M Sell
1,796,477
-204,990
-10% -$3.14M 0.7% 43
2019
Q1 		$34.5M Sell
2,001,467
-226,040
-10% -$3.58M 1.01% 33
2018
Q4 		$28.5M Sell
2,227,507
-7,900
-0.4% -$120K 1.14% 30
2018
Q3 		$36.3M Buy
2,235,407
+200
+0% +$2.86K 1.12% 32
2018
Q2 		$28.8M Sell
2,235,207
-234,480
-9% -$3.17M 0.98% 35
2018
Q1 		$30.7M Buy
2,469,687
+151,300
+7% +$1.84M 1.19% 30
2017
Q4 		$32.4M Buy
2,318,387
+266,900
+13% +$3.91M 1.41% 26
2017
Q3 		$34.5M Sell
2,051,487
-104,462
-5% -$1.7M 1.7% 19
2017
Q2 		$36.3M Buy
2,155,949
+151,100
+8% +$2.26M 2.21% 14
2017
Q1 		$31.1M Buy
2,004,849
+303,800
+18% +$4.34M 2.02% 17
2016
Q4 		$25.4M Buy
1,701,049
+269,930
+19% +$3.79M 2.19% 17
2016
Q3 		$18M Buy
1,431,119
+3,025
+0.2% +$30.4K 1.43% 24
2016
Q2 		$12.9M Buy
1,428,094
+552,006
+63% +$5.41M 1.23% 29
2016
Q1 		$8.68M Buy
876,088
+15,800
+2% +$162K 0.89% 28
2015
Q4 		$9.89M Sell
860,288
-167,844
-16% -$2.08M 0.74% 31
2015
Q3 		$13.9M Sell
1,028,132
-184,760
-15% -$2.5M 1.05% 26
2015
Q2 		$16.8M Sell
1,212,892
-202,590
-14% -$2.74M 1.38% 29
2015
Q1 		$19.9M Buy
1,415,482
+344,487
+32% +$4.69M 1.79% 19
2014
Q4 		$14.6M Buy
1,070,995
+4,580
+0.4% +$62.6K 1.59% 31
2014
Q3 		$16.3M Buy
1,066,415
+105,595
+11% +$1.62M 1.88% 22
2014
Q2 		$16.2M Buy
960,820
+335,951
+54% +$6.05M 1.96% 28
2014
Q1 		$12.5M Sell
624,869
-321,588
-34% -$6.96M 1.5% 30
2013
Q4 		$18.3M Buy
+946,457
New +$16.7M 2.26% 19

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Redmile Group's OXFD Position: Q3 2019 in Review

Redmile Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 1,796,477 shares — an estimated $24.7M sold.

Redmile Group first reported a position in OXFD in Q4 2013 and held it in 23 quarters. The position peaked at $36.3M in Q3 2018. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

  • Redmile Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • Redmile Group sold 1,796,477 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $24.7M.
  • Redmile Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 23 quarters.
  • Redmile Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $36.3M in Q3 2018.
  • 73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Redmile Group's 13F filing for Q3 2019, filed 14 Nov 2019.